<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01654133</url>
  </required_header>
  <id_info>
    <org_study_id>12-0644</org_study_id>
    <nct_id>NCT01654133</nct_id>
  </id_info>
  <brief_title>Visceral (Kidney and Abdominal Organ) Function After Fenestrated and Branched Endovascular Aneurysm Repair (FEVAR/BEVAR) of Thoracoabdominal Aortic Aneurysms</brief_title>
  <official_title>Evaluation of Visceral Function Following Fenestrated Endovascular Aortic Aneurysm Repair (FEVAR) Using Branch Stent-Grafts</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of North Carolina, Chapel Hill</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>UNC Hospitals</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Cook Group Incorporated</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of North Carolina, Chapel Hill</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate visceral function, after endovascular repair of
      thoracoabdominal aneurysms.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will evaluate the effect of endovascular repair of thoracoabdominal aortic
      aneurysms (Types I-IV) on visceral function using custom manufactured and off the shelf stent
      grafts. Specifically, the device orientation and configuration will be evaluated with respect
      to renal function. Since detailed CT scan imaging will be performed prior to and after
      endovascular repair, critical data concerning each branched vessel length, tangential
      orientation from the aorta, angle of incidence, and diameter can be determined. This
      information can then be coupled with hemodynamic data obtained from duplex ultrasonography as
      well as changes in renal volume, estimated glomerular filtration rate (eGFR), and flow
      characteristics over time. By analyzing the data in this fashion, it may be possible to
      determine changes in hemodynamics and/or physiologic conditions with respect to branched
      stent-graft design characteristics. These data may be utilized to enhance current device
      design and improve patient outcomes. The FDA has approved the use of commercially available
      devices to be used in conjunction with the investigational device if the Investigator deems
      this necessary.
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date>July 2012</start_date>
  <completion_date type="Anticipated">August 2021</completion_date>
  <primary_completion_date type="Anticipated">August 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline in renal function over time (up to two years) after endovascular aortic aneurysm repair various custom stent grafts</measure>
    <time_frame>Pre-procedure and 1, 6, 12, 18, and 24 months post procedure</time_frame>
    <description>Visceral function after endovascular repair of pararenal aneurysms using various custom stent grafts. Specifically, the device orientation and configuration will be evaluated with respect to renal function over time. Critical data concerning each branched vessel from radiological studies coupled with hemodynamic data obtained from renal artery duplex, changes in renal volume, eGFR, and flow characteristics at 1, 6, 12, 18 and 24 months post procedure may make it possible to determine changes in renal function.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to morbidity</measure>
    <time_frame>30 days and 1 &amp; 2 years post procedure</time_frame>
    <description>Morbidity at 30 days, 1 &amp; 2 years post procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to mortality</measure>
    <time_frame>30 days and 1 &amp; 2 years post procedure</time_frame>
    <description>Mortality at 30 days, 1 &amp; 2 years post procedure.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to loss of stent graft integrity</measure>
    <time_frame>30 days and 1 &amp; 2 years post procedure</time_frame>
    <description>Evidence on contrast CT angiography of loss of stent graft integrity at 30 days, and one and two years post procedure.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to migration</measure>
    <time_frame>30 days and 1 &amp; 2 years post procedure</time_frame>
    <description>Evidence of stent graft migration on abdominal x-rays at 30 days and 1 &amp; 2 years.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Endoleak</measure>
    <time_frame>30 days and 1 &amp; 2 years post procedure</time_frame>
    <description>Evidence of Endoleak on contrast CT angiography of abdomen 30 days and 1 &amp; 2 years post procedure.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Branch vessel Events</measure>
    <time_frame>30 days and 1 &amp; 2 years post procedure</time_frame>
    <description>Evidence of branch vessel events on contrast CT angiography and renal duplex 30 days, and 1 &amp; 2 years post procedure.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Aortic Aneurysm, Abdominal</condition>
  <arm_group>
    <arm_group_label>endovascular repair TAAA</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Endovascular repair of thoracoabdominal aortic aneurysm (TAAA) using Branched stent grafts</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Endovascular repair of thoracoabdominal aortic aneurysm (TAAA) using branched stent graft</intervention_name>
    <description>Repair of thoracoabdominal aortic aneurysms</description>
    <arm_group_label>endovascular repair TAAA</arm_group_label>
    <other_name>Endovascular repair of thoracoabdominal aortic aneurysm</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Patients may be included in the study if the patient has at least one of the following and
        has aortic anatomy appropriate for treatment with the Zenith® p-Branch™, Zenith® t-Branch,
        or Physician Specified TAAA Endovascular Graft (Custom Manufactured Devices).

          1. Aortic Aneurysm Diameter

               1. TAAA (Type I - IV) (including pararenal subtypes) with orthogonal aortic diameter
                  greater than or equal to 5 cm or

               2. greater than two times the normal aortic diameter

          2. Rapid aortic enlargement (&gt; than or equal to 5mm in 1 year)

          3. Presence of a saccular aneurysm at risk for rupture based on investigators evaluation

          4. Iliac artery aneurysm ˃2.2 cm may be treated with the Zenith® Branch Endovascular
             Graft-Iliac Bifurcation when the iliac artery aneurysm is associated with the
             qualifying thoracoabdominal aneurysm treated in this study

        Exclusion Criteria:

        General Exclusion Criteria

        Patients must be excluded from the study if any of the following conditions are true:

          1. Less than 18 years of age

          2. Unwilling to comply with the follow-up schedule

          3. Inability or refusal to give informed consent

        Medical Exclusion Criteria

        Patients must be excluded from the study if any of the following conditions are true:

          1. Known sensitivities or allergies to stainless steel, nitinol, polyester, solder (tin,
             silver), polypropylene, urethane or gold

          2. History of anaphylactic reaction to contrast material that cannot be adequately
             premedicated

          3. Leaking, ruptured aneurysm associated with hypotension

          4. Uncorrectable coagulopathy

        Anatomical Exclusion Criteria

        Patients must be excluded from the study if any of the following conditions are true:

          1. Inadequate femoral/iliac access compatible with the required delivery systems;

          2. Does not have a non-aneurysmal aortic segment proximal to the aneurysm with:

               1. A length of at least 4 mm, i.e. at least 4 mm circumferential wall contact around
                  the limits of scallop

               2. A diameter measured outer wall to outer wall of no greater than 31mm and no less
                  than 21 mm;

               3. An angle less than 60 degrees relative to the centerline of the aneurysm;

               4. An angle less than 45 degrees relative to the supraceliac aorta.

          3. Does not have visceral vessel anatomy compatible with Zenith® p-Branch™, specifically:

               1. Renal vessel origins as measured relative to the superior mesenteric artery (SMA)
                  compatible with the renal fenestration, i.e. Both renal vessel origins within
                  7.5mm of the corresponding renal fenestrations;

               2. Celiac vessel origin as measured relative to the superior mesenteric artery (SMA)
                  compatible with the celiac scallop.

          4. A proximal seal site with unsuitable thrombus/atheroma

          5. Does not have iliac artery fixation sites and anatomy consistent with:

               1. Common iliac artery fixation site diameter, measured outer wall to outer wall on
                  a sectional image (CT) &lt;8.0 mm (prior to deployment)

               2. Iliac artery diameter, measured outer wall to outer wall on a sectional image
                  (CT) &gt;21 mm at distal fixation site

               3. Iliac artery distal fixation site &lt;10 mm in length

               4. Inability to preserve at least one hypogastric artery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mark A Farber, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of North Carolina, Chapel Hill, NC 27599</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UNC Heart and Vascular</name>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <zip>27599</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 27, 2012</study_first_submitted>
  <study_first_submitted_qc>July 27, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 31, 2012</study_first_posted>
  <last_update_submitted>May 7, 2018</last_update_submitted>
  <last_update_submitted_qc>May 7, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 14, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Aortic Aneurysm, abdominal</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm, Abdominal</mesh_term>
    <mesh_term>Aortic Aneurysm, Thoracic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

